Avidian Gold Corp Class A Azioni (OTC: AVGDD)

Ultime notizie per Avidian Gold Corp Class A (OTC:AVGDD) Azioni

Avidian Gold Corp Class A

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MD#NYSE">MD</a>) with a Neutral and lowers the price target from $18.5 to $16.

News

Price Target

Analyst Ratings

UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $16

<a href="https://www.nytimes.com/2025/05/12/business/economy/trump-chip-sale-to-emirati-ai-firm-g42.html?searchResultPosition=1" title="https://www.nytimes.com/2025/05/12/business/economy/trump-chip-sale-to-emirati-ai-firm-g42.html?searchResultPosition=1">https://www.nytimes.com/2025/05/12/business/economy/trump-chip-sale-to-emirati-ai-firm-g42.html?searchResultPosition=1</a>

Macro Economic Events

Global

Economics

MSFT

'Trump Administration Considers Large Chip Sale to Emirati A.I. Firm G42' - NY Times

UBS analyst Manav Gupta maintains Ballard Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDP#NASDAQ">BLDP</a>) with a Neutral and lowers the price target from $2 to $1.4.

BLDP

UBS Maintains Neutral on Ballard Power Systems, Lowers Price Target to $1.4

Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) shares jumped 6.3% to $210.75 on Monday afternoon, following a breakthrough in <a href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling">trade negotiations</a> between the United States and China that could significantly benefit the tech giant's global operations.
What To Know: Apple, heavily reliant on a China-centric supply chain for manufacturing iPhones, MacBooks and other hardware, was a clear beneficiary of the temporary rollback in tariffs announced over the weekend. 
The new agreement includes a <a href="https://www.benzinga.com/markets/equities/25/05/45341884/apple-amazon-nvidia-rise-in-monday-premarket-as-us-china-agree-to-90-day-tariff-truce-neither-side-wants-a-decoupling">90-day suspension</a> of reciprocal tariffs, slashing duties on a broad range of goods from 125% to just 10%, while also lifting Chinese export restrictions on critical materials used in semiconductor and battery production.
Read Also: <a href="https://www.benzinga.com/news/25/05/45354329/netease-ntes-stock-rallies-as-easing-trade-tensions-lift-chinese-tech">NetEase Stock Rallies As Easing Trade Tensions Lift Chinese Tech</a>
This de-escalation eases pressure on Apple's manufacturing partners such as Foxconn and Pegatron, both of which <a href="https://www.benzinga.com/media/25/03/44229157/apple-supplier-foxconn-unveils-ai-model-using-nvidia-tech">operate extensively</a> in China. The tariff reduction potentially serves as a direct cost relief that could protect Apple's margins heading into its next iPhone cycle.
Additionally, the suspension of non-tariff Chinese sanctions on U.S. firms improves Apple's operating environment in one of its largest markets. With China accounting for <a href="https://www.apple.com/newsroom/pdfs/fy2024-q4/FY24_Q4_Consolidated_Financial_Statements.pdf">roughly 18%</a> of Apple's revenue, the deal could alleviate fears of further regulatory retaliation.
Read Also: <a href="https://www.benzinga.com/25/05/45357593/tesla-stock-is-climbing-monday-whats-going-on">Tesla Stock Is Climbing Monday: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy AAPL Stock</h2>
By now you're likely curious about how to participate in the market for Apple &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Apple, which is trading at $210.75 as of publishing time, $100 would buy you 0.47 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, AAPL has a 52-week high of $260.09 and a 52-week low of $169.21.

AAPL

Apple Stock Rises Following US-China Trade Breakthrough

UBS analyst Alex Kramm maintains Verisk Analytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>) with a Neutral and raises the price target from $295 to $320.

VRSK

UBS Maintains Neutral on Verisk Analytics, Raises Price Target to $320

UBS analyst Josh Silverstein maintains Permian Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PR#NYSE">PR</a>) with a Buy and raises the price target from $14 to $16.

UBS Maintains Buy on Permian Resources, Raises Price Target to $16

Shares of major machinery companies, including AGCO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>), Caterpillar Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) and Cummins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) are trading higher Monday afternoon after the United States and China reached a temporary agreement to slash tariffs <a href="https://www.benzinga.com/government/regulations/25/05/45347089/wall-street-rips-higher-as-tariff-truce-halts-us-china-economic-escalation">on each other's goods. </a>
What To Know: The rally reflects broad optimism that reduced trade barriers xould ease supply chain constraints and boost business confidence in the industrial and manufacturing sectors.
The tariff rollback, announced after talks in Geneva between U.S. Treasury Secretary Scott Bessent and China's Vice Premier He Lifeng, cuts U.S. tariffs on Chinese goods from 145% to 30% and reduces Chinese tariffs on American goods from 125% to 10%. The reductions take effect on May 14 and are scheduled to last for 90 days as both countries assess next steps in their trade relationship.
Companies in the machinery and industrial equipment space are among the most directly impacted by such tariffs, given their reliance on international supply chains and global demand for capital goods.
Wall Street responded positively, with major equity futures rising across the board. S&amp;P 500 futures jumped 3.1%, Nasdaq futures surged over 4% and Dow futures gained more than 2.6%. The dollar strengthened while gold prices declined, reflecting a shift away from safe-haven assets.
Price Action: AGCO shares are up 6.55% to $105.85, Caterpillar shares gained 5.4% to $343.21 and Cummins shares jumped 7.6% to $330.01, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45357613/china-tariff-de-escalation-biggest-winners-include-tesla-apple-new-tech-highs-back-on-the-table-now-for-2025">China Tariff De-Escalation Biggest Winners Include Tesla, Apple: &#8216;New Tech Highs Back On The Table Now For 2025&#8217; </a></li>
</ul>

Movers

AGCO

Machinery Stocks Surge As US–China Tariff Truce Eases Trade Pressures: What's Going On?

UBS analyst Timothy Arcuri maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and lowers the price target from $180 to $175.

NVDA

UBS Maintains Buy on NVIDIA, Lowers Price Target to $175

Trading Ideas

INHD

Inno Holdings Shares Halted On Circuit Breaker To The Downside, Stock Now Down -59.1%

Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares are trading higher Monday following news that the United States and China have agreed to a 90-day <a href="https://www.benzinga.com/government/regulations/25/05/45347089/wall-street-rips-higher-as-tariff-truce-halts-us-china-economic-escalation">rollback of trade tariffs.</a>
What To Know: The agreement is lifting major chipmakers and trade-sensitive stocks across Wall Street, with Nvidia among the top gainers in the sector.
The temporary trade truce, announced after high-level negotiations in Geneva, slashes U.S. tariffs on Chinese goods from 145% to 30% and cuts Chinese tariffs on U.S. goods from 125% to 10%, effective May 14. U.S. Treasury Secretary Scott Bessent and China's Vice Premier He Lifeng brokered the deal, which is expected to reduce inflationary pressures and supply chain bottlenecks that have plagued the semiconductor and electronics sectors since early April.
The agreement marks a pause in what had been an aggressive tariff escalation launched under President Trump's "Liberation Day" policy last month. Markets reacted swiftly, with S&amp;P 500 futures jumping over 3%, the Nasdaq 100 rising more than 4% and semiconductor stocks seeing broader gains.
The tariff cuts are also expected to lower input costs and stabilize global demand for electronics and industrial equipment, both critical to Nvidia's ecosystem. As the news broke, chip stocks including Microchip Technology, ON Semiconductor and Nvidia all saw strong gains, with Nvidia outperforming most of its peers.
While Nvidia's rise is partly driven by the broader sector rally, it also reflects the company&#8217;s pivotal role in industries heavily affected by trade policy, including AI, data centers and high-performance computing. Investors are rotating out of defensive assets like gold and into equities, betting that easing trade tensions will lead to stronger earnings and investment activity in the second half of the year.
NVDA Price Action: Nvidia shares were up 4.87% at $122.34 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45357613/china-tariff-de-escalation-biggest-winners-include-tesla-apple-new-tech-highs-back-on-the-table-now-for-2025">China Tariff De-Escalation Biggest Winners Include Tesla, Apple: &#8216;New Tech Highs Back On The Table Now For 2025&#8217; </a></li>
</ul>

Nvidia Stock Surges Over 5%: What's Going On?

DEVS

DevvStream Shares Resume Trade Following Circuit Breaker Halt

The Federal Circuit rejects Bruker Cellular's invalidity challenge to AbCellera's patent for microfluidic devices and their use in culturing cells
AbCellera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABCL#NASDAQ">ABCL</a>) today announced that the United States Court of Appeals for the Federal Circuit (CAFC) has by a Rule 36 Order affirmed judgment of validity of its U.S. Patent No. 10,087,408 ("the ‘408 Patent"). AbCellera's ‘408 Patent is directed to microfluidic devices and using such devices to culture and selectively recover cells.
Previously Berkeley Lights Inc., now Bruker Cellular Analysis, Inc. (Bruker), a subsidiary of Bruker Corporation, challenged the claims of the ‘408 Patent alleging invalidity based on anticipation and obviousness over the prior art. The U.S. Patent Trial and Appeal Board (PTAB) rejected all of Bruker's arguments and now the CAFC has confirmed that all claims of AbCellera's ‘408 Patent are valid. AbCellera's ‘408 Patent is part of a multi-patent infringement litigation between AbCellera and Bruker pending in the U.S. District Court for the Northern District of California.

Legal

ABCL

BRKR

AbCellera Announces The Federal Circuit Upholds Validity Of Its '408 Patent On Microfluidic Cell-Culturing Devices, Rejecting Bruker Cellular's Invalidity Challenge And Strengthening AbCellera's Position In Ongoing Patent Litigation.

Bill Gates, the co-founder of Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and a tech industry titan, recently announced plans to give away 99% of his wealth by 2045, but not everyone is convinced.&nbsp;
The billionaire, who became the world's youngest <a href="https://www.benzinga.com/startups/24/12/42419457/bill-gates-billionaire-success-was-fueled-by-a-crucial-childhood-habit-thats-nearly-extinct-today-heres-why-thats-a-problem">self-made billionaire</a> at age 31 in 1987 and the first centibillionaire in 1999, currently holds a net worth of $113 billion, making him the 13th-richest person in the world, according to Forbes.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">A Billionaire&#8217;s Bold Promise</h2>
The 69-year-old philanthropist outlined his latest giving pledge in a <a href="https://www.gatesnotes.com/home/home-page-topic/reader/n20-years-to-give-away-virtually-all-my-wealth">blog post</a>, declaring that his Bill &amp; Melinda Gates Foundation will <a href="https://www.benzinga.com/markets/25/05/45286464/bill-gates-commits-99-of-his-remaining-fortune-to-gates-foundation-set-to-wind-down-in-20-years-somebody-should-give-more-money-than-i-did">wind down its operations by 2045</a>, aiming to donate another $200 billion in that time.&nbsp;
Gates, who once held the title of the world's richest person for 18 of 24 years between 1995 and 2017, said he does not want to be remembered as someone who "died rich."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I&#39;ve been hearing this for 15 years and every year Bill has more. <a href="https://t.co/QTRw6zdMuE">https://t.co/QTRw6zdMuE</a>
&mdash; Coffeezilla (@coffeebreak_YT) <a href="https://twitter.com/coffeebreak_YT/status/1920723618482327789?ref_src=twsrc%5Etfw">May 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trending: The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">invest early at $2.25/share.</a>
However, the response online has been mixed. Popular YouTuber Stephen Findeisen, better known as Coffeezilla, was among those expressing doubt, <a href="https://x.com/coffeebreak_YT/status/1920723618482327789">posting on X</a>, "I've been hearing this for 15 years and every year Bill has more." The post got a lot of similar responses, with some questioning if Gates&#8217; promise is about real giving or just maintaining influence.
"They're likely just putting it into a trust and then ‘giving it away' over the course of 50-100 years," one commenter, Sam Tayyari, <a href="https://x.com/samtayyari/status/1920724915323306365">suggested</a>, adding that many charities "spend a lot on ‘administrative costs' like private jetting to give a 10 min speech while staying in $10k/night resorts."
Others pointed out that even giving away 99% of his fortune would still leave Gates a billionaire, with one user <a href="https://x.com/im_deiting/status/1920724966871314829">noting</a>, "1% of $200 billion is $2 billion. That&#8217;s a lot of money too."
Critics also drew comparisons to other wealthy figures, like George Soros, who have faced similar skepticism about their charitable efforts. One commenter <a href="https://x.com/Mountain_Texan/status/1920724460199412109">argued</a>, "It's meaningless anyway. He's going to ‘give it away' in the same way Soros gave his money away. He's purchasing influence, not giving money away."
See Also: <a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a>
Gates, who has said he was inspired by <a href="https://www.benzinga.com/personal-finance/25/05/45240439/ive-made-no-sacrifice-warren-buffett-has-given-away-60-billion-but-says-giving-time-is-more-admirable-ive-done-little-of-that">philanthropists like Warren Buffett</a> and 19th-century industrialist Andrew Carnegie, acknowledged that his approach to giving is about urgency.&nbsp;
In a recent BBC <a href="https://www.bbc.com/news/articles/cx2e87lzqkdo">interview</a>, he said, "It's really about the urgency. We can spend a lot more if we're not trying to be perpetual, and I know that the spending will be in line with my values."
According to Gates, the foundation has already distributed $100 billion for health and development projects and plans to spend another $200 billion in the coming decades, depending on markets and inflation. However, critics argue that the true impact of these donations can be difficult to measure, given the scale of his wealth and the complex structures often used in philanthropy.
Despite the skepticism, Gates remains committed to his vision, saying in his blog post, "People will say a lot of things about me when I die, but I am determined that ‘he died rich' will not be one of them."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Popular YouTuber Coffeezilla Is Puzzled By Bill Gates' Philanthropy Plans—'I've Been Hearing This For 15 Years And Every Year Bill Has More'

WIIM

SATS

EchoStar shares are trading lower following a report suggesting that the FCC told chairman and co-founder Charlie Ergen that the agency staff would investigate the company's compliance with federal requirements to build a 5G network.

Cryptocurrency markets are down on Monday after Bitcoin peaked above $105,000 in early trading hours.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$102,002.91</td>
<td>-2.5%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,459.63</td>
<td>-2%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$170.91</td>
<td>-1%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.48</td>
<td>-4.7%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.2274</td>
<td>-1.9%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001542</td>
<td>-3.6%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume increasing by 3% and daily active addresses falling by 7.4%. Transactions greater than $100,000 are down from 9,463 to 8,934 in a single day. Exchanges netflows are down by 388.7%.</li>
<li>Coinglass data reports 178,950 traders were liquidated in the past 24 hours for $556.54 million. Bitcoin long liquidations spiked to the highest level since April 7.</li>
<li>Bitcoin held by U.S. spot ETFs has climbed to 1.175 million BTC, just 6,500 BTC shy of its all-time high of 1.182 million, according to Glassnode <a href="https://x.com/glassnode/status/1921911197198090255">data</a>.</li>
<li>Crypto chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1921943951268819201">reports</a> Bitcoin miners having realized over $10.37 million in profits, signaling improved miner profitability.</li>
<li>Sentora <a href="https://x.com/SentoraHQ/status/1921969105332023660">notes</a> that after Bitcoin surpassed $100,000, exchange flows turned sharply negative with $550 million in BTC withdrawn on Friday alone, indicating strong accumulation by investors.</li>
</ul>
Notable Developments:
<ul class="wp-block-list">
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/05/45344230/exclusive-defi-development-makes-record-solana-purchase-surpasses-100-million-in-treasury-holdings">EXCLUSIVE: DeFi Development Makes Record Solana Purchase, Surpasses $100 Million In Treasury Holdings</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45354779/stanford-warns-future-of-crypto-depends-on-regulation-quantum-safe-systems-digital-dollar-competition">Stanford Warns Future Of Crypto Depends On Regulation, Quantum-Safe Systems, Digital Dollar Competition</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45355405/coinbases-subscription-gains-deribit-acquisition-blockchain-revenue-strength-prompt-analyst-support">Coinbase&#8217;s Subscription Gains, Deribit Acquisition, Blockchain Revenue Strength Prompt Analyst Support</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45352237/nakamoto-holdings-raises-710m-merges-with-kindlymd-to-build-bitcoin-treasury-holding-company">Nakamoto Holdings Raises $710M, Merges With KindlyMD To Build Bitcoin Treasury Holding Company</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45349057/strategy-buys-134b-in-bitcoin-at-99856-cites-155-btc-yield">Strategy Buys $1.34B In Bitcoin At $99,856, Cites 15.5% BTC Yield</a></li>
<li><a href="https://www.benzinga.com/markets/25/05/45349144/billionaire-tim-draper-says-businesses-that-are-not-holding-bitcoin-in-their-treasuries-are-being-ir">Billionaire Tim Draper Says Businesses That Are Not Holding Bitcoin In Their Treasuries Are &#8216;Being Irresponsible&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45340929/cathie-wood-highlights-analysts-take-more-than-humans-crypto-was-made-for-ai">Cathie Wood Highlights Analyst&#8217;s Take: &#8216;More Than Humans, Crypto Was Made For AI&#8217;</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>$1.11</td>
<td>+23.8%</td>
</tr>
<tr>
<td>Four (CRYPTO: FORM)</td>
<td>$2.78</td>
<td>+17.6%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.48&nbsp;</td>
<td>+4.6%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Altcoin Sherpa remains bullish on Bitcoin long-term but warns of a likely pullback in the short term, though the timing and depth remain unclear.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">im still bullish <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> but I&#39;m still going to keep posting this chart as a reminder to myself and others that we &#x2A;probably&#x2A; see some sort of pullback soon (in theory). I&#39;m not sure when/how deep but yeah. <a href="https://t.co/gR36Bgn6eV">https://t.co/gR36Bgn6eV</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1921968703727419659?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Voicing a similar opinion, Sherpa <a href="https://x.com/AltcoinSherpa/status/1921973201770332279">advised</a> that if anyone is looking to buy Bitcoin for long-term positions and aren&#8217;t very active, it&#8217;s probably best to wait for a dip, potentially to the low to mid $90,000s.
ShardiB2 <a href="https://x.com/ShardiB2/status/1921979353820225736">points </a>to $103,400 as a critical daily close level. A close above would invalidate a potential local top, but advises caution for longs at current levels, noting higher time frame signals are more reliable. 
Meanwhile, Kaleo speculates whether Bitcoin is positioning itself for a massive upside scenario, potentially spiking to $520,000 in the longer term.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> / <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Are you ready for this scenario? <a href="https://t.co/PxHMB3Xzso">pic.twitter.com/PxHMB3Xzso</a>
&mdash; K A L E O (@CryptoKaleo) <a href="https://twitter.com/CryptoKaleo/status/1921979557348810813?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Cryptomist <a href="https://x.com/Thecryptomist/status/1921956911454323107">sees</a> Bitcoin CME gap having been filled, and the user now expects BTC to move toward $108,000. Altcoins are anticipated to follow the upward move.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45354990/scottie-pippen-declares-altcoin-season-as-ethereum-xrp-dogecoin-shiba-inu-rally">Scottie Pippen Declares &#8216;Altcoin Season&#8217; As Ethereum, XRP, Dogecoin, Shiba Inu Rally</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

$DOGE

$ETH

$SHIB

$SOL

$WIF

$XRP

Bitcoin, Ethereum, Dogecoin Slip While XRP Holds Firm: Is A Pullback Coming?

Shares of Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) soared 8.1% to $208.68 Monday afternoon after the U.S. and China <a href="https://www.benzinga.com/government/regulations/25/05/45355655/magnificent-seven-gain-700b-after-us-china-slash-tariffs-gold-crashes-whats-driving-markets-monday">announced</a> a temporary easing of tariffs, marking a significant step toward de-escalating long-standing trade tensions. The move lifted investor sentiment across sectors and boosted shares of companies heavily reliant on global supply chains.
What To Know: Amazon stands to benefit directly from the tariff reprieve. As one of the world's largest e-commerce and cloud services companies, Amazon is deeply integrated with global manufacturing, particularly in <a href="https://www.benzinga.com/government/regulations/25/05/45348699/us-listed-chinese-stocks-rally-as-countries-agree-to-ease-import-tariffs">China</a>.
Read Also: <a href="https://www.benzinga.com/news/25/05/45355529/needham-says-draftkings-dkng-q1-handle-should-calm-fears">Needham Says DraftKings Q1 Handle Should &#8216;Calm Fears&#8217;</a>
Many of the products sold on Amazon's marketplace—including electronics, consumer goods and private-label brands—are sourced or assembled in Chinese factories. Lower import tariffs reduce the company's cost of goods sold, improving profit margins across its retail segment.
Additionally, Amazon Web Services could gain ground in international markets amid improving geopolitical relations, as fewer regulatory frictions may ease data localization pressures and expand enterprise cloud adoption in Asia.
Beyond its direct exposure, Amazon's stock rise also reflects <a href="https://www.benzinga.com/government/regulations/25/05/45347089/wall-street-rips-higher-as-tariff-truce-halts-us-china-economic-escalation">broader bullish sentiment</a> in tech during Monday&#8217;s session. With global supply chains potentially stabilizing and trade risk easing, investors could be pricing in stronger revenue growth, improved logistics and greater consumer confidence heading into the second half of the year.
Read Also: <a href="https://www.benzinga.com/news/25/05/45354368/why-marvell-technology-mrvl-stock-is-soaring-today">Why Marvell Technology Stock Is Soaring Today</a>
<h2 class="wp-block-heading">How To Buy AMZN Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Amazon&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, AMZN has a 52-week high of $242.52 and a 52-week low of $151.61.

AMZN

Amazon (AMZN) Stock Soars 8% Monday: What's Going On?

Goldman Sachs analyst Michael Ng <a target="_blank" href="https://www.benzinga.com/quote/PARA/analyst-ratings" rel="noreferrer noopener">remained Not Rated</a> on Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>) on Friday.
Revenue of $7.19 billion beat Ng and consensus estimate of $7.04 billion and $7.1 billion.
Adjusted OIBDA of $688 million beat $652 million and $666 million Ng and consensus estimate driven by a broad-based beat across DTC, TV Media, and Film.
Also Read: <a href="https://www.benzinga.com/25/03/44120055/paramount-gains-engagement-but-tv-and-film-struggles-lead-to-analyst-outlook-revision" target="_blank" rel="noreferrer noopener">Paramount Faces PayTV Declines, But Streaming And Licensing Gains Prompt Analyst Estimate Revisions</a>
TV Media advertising was flat on an underlying basis on Super Bowl comps, helped by strong sports programming like March Madness and the NFL Playoffs.
Like Warner Bros. Discovery, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>), advertising outperformed, and there has been limited discernible impact from macro uncertainty, Ng noted.
DTC advertising declined 1% on an underlying basis on Super Bowl comps, which should continue throughout 2025, driven by growing industry AVOD supply (e.g., Amazon.Com Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>)) as per the analyst.
The analyst remarked that Paramount expects the proposed Skydance acquisition to close in the first half of 2025. Free cash flow of $123 million beat the analyst&#8217;s estimate of $69 million and $13 million.
DTC revenue of $2.04 billion missed the consensus estimates of $2.1 billion and $2.09 billion, with OIBDA of $(109) million above the analyst and the consensus estimates of $(128) million and $(153) million. Paramount+ subscribers increased to 79.0 million (versus Ng&#8217;s estimate of 78.6 million), and global Paramount+ revenue grew 16% (versus Ng&#8217;s estimate of +12%).
TV Media revenue of $4.54 billion beat Ng and consensus estimate of $4.39 billion and $4.43 billion, with OIBDA of $922 million beating Ng estimate of $904 million but missing consensus of $951 million.
Filmed Entertainment revenue of $627 million was above Ng and consensus estimate of $575 million and $610 million, with OIBDA of $20 million beating Ng and consensus estimate of $13 million and $17 million.
Paramount introduced second-quarter guidance including subscriber decline at Paramount+ due to content seasonality and termination of an international bundle, Paramount+ ARPU growth to accelerate off first-quarter 2025, TV Media affiliate revenue decline rates to see similar underlying trends versus first-quarter 2025, TV Media advertising to see similar underlying trends versus first-quarter 2025 in digital while deceleration in linear, OIBDA loss in Studios driven by costs associated with the release of Mission Impossible &#8211; The Final Reckoning and free cash flow to Mirror last year.
Paramount reiterated 2025 guidance, including OIBDA, which will modestly decline, including impacts from the Super Bowl, free cash flow, which will increase, including 2024 Super Bowl and political advertising impacts, and domestic profitability for Paramount+.
The analyst projects fiscal 2025 revenue of $28.7 billion and adjusted EPS of $0.81.
Price Action:&nbsp;PARA stock is up 0.50% by $12.00 at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45192411/netflix-stock-drops-as-trumps-proposed-tariffs-on-foreign-films-spark-concerns" target="_blank" rel="noreferrer noopener">Netflix And Other Streaming Stocks Slide As Trump&#8217;s Proposed Tariffs On Foreign Films Sparks Concern</a></li>
</ul>

Analyst Color

Entertainment

Tech

Media

PARA

PARAA

Paramount's Super Bowl Boost And Studio Strength Help Offset Streaming Miss: Analyst

Humacyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Humacyte will report an earnings per share (EPS) of $-0.21.
The market awaits Humacyte's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.09, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Humacyte's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.25</td>
<td>-0.25</td>
<td>-0.24</td>
<td>-0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.16</td>
<td>-0.33</td>
<td>-0.27</td>
<td>-0.29</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>10.0%</td>
<td>-10.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747077165_0.png" alt="eps graph" />
<h3>Market Performance of Humacyte's Stock</h3>
Shares of Humacyte were trading at $1.19 as of May 09. Over the last 52-week period, shares are down 79.52%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/HUMA/earnings">To track all earnings releases for Humacyte visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

HUMA

Exploring Humacyte's Earnings Expectations

Cellectar Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Cellectar Biosciences will report an earnings per share (EPS) of $-0.16.
Anticipation surrounds Cellectar Biosciences's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.34, which was followed by a 5.34% increase in the share price the next day.
Here's a look at Cellectar Biosciences's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.35</td>
<td>-0.37</td>
<td>-1</td>
<td>-0.72</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.01</td>
<td>-0.40</td>
<td>-0.18</td>
<td>-0.74</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>-9.0%</td>
<td>0.0%</td>
<td>6.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747077057_0.png" alt="eps graph" />
<h3>Market Performance of Cellectar Biosciences's Stock</h3>
Shares of Cellectar Biosciences were trading at $0.2474 as of May 09. Over the last 52-week period, shares are down 91.9%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CLRB/earnings">To track all earnings releases for Cellectar Biosciences visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLRB

Insights Ahead: Cellectar Biosciences's Quarterly Earnings

<a href="https://www.biorxiv.org/content/10.1101/2025.05.09.652772v1">https://www.biorxiv.org/content/10.1101/2025.05.09.652772v1</a>

Biotech

General

AEMD

Watching Aethlon Medical; Traders Circulate Article From bioRxiv: "Ex Vivo Removal of CD41 positive platelet microparticles from Plasma by a Medical Device containing a Galanthus nivalis agglutinin (GNA) affinity resin (Aethlon Medical's Hemopurifier)"

Comments

Avidian Gold Corp Class A

Notizie

Ultime notizie per Avidian Gold Corp Class A (OTC:AVGDD) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO